AirSculpt

Management paused new center openings to preserve liquidity and shifted spend to ROI-tested marketing, which is sensible given softer demand. However, the playbook depends on ongoing brand advertising and lead conversion, where payback can vary.

The company has relied on external capital: an underwritten offering in 2025, an active 50 million ATM program that raised ~19.6 million in H1 2026 plus additional Q3 issuance, and accelerated debt paydowns.

While deleveraging is prudent, equity issuance at depressed valuations is dilutive; weighted-average shares rose roughly 19 percent year over year in Q2 2026. There is no dividend or buyback and M&A is minimal, which we view positively. Overall, allocation is pragmatic given constraints but not value-accretive for long-term owners so far.